News Atlas closes $450m biotech fund, and other financing news Atlas Venture raised $450m for its fourteenth biotech round, while Nuvig, Maze, and Antag also closed financings this week.
News Guidance creates access gap in UK for GPP drug Spevigo People in England and Wales with severe skin disease GPP will soon be able to access a new therapy currently denied to patients in Scotland.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
